Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelinesAmy J. Davidoff, Steven D. Gore, Sheila R. Weiss et al.|Leukemia Research|2013Cited by 31
Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticariaLiya Wang, Lisa A. Beck, Xuehua Ke et al.|Current Medical Research and Opinion|2017Cited by 14
Real-world Clinical Characteristics, Treatment Patterns, and Exacerbations in US Patients With Asthma Newly Treated With OmalizumabXuehua Ke, Jonathan Corren, Abhishek Kavati et al.|Clinical Therapeutics|2018Cited by 13
Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United StatesXuehua Ke, Lisa A. Beck, Abhishek Kavati et al.|Journal of Managed Care & Specialty Pharmacy|2018Cited by 13
Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United StatesXuehua Ke, Lisa A. Beck, Abhishek Kavati et al.|Journal of Managed Care & Specialty Pharmacy|2017Cited by 8